Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adi Vaknin

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Expert Review of Clinical Immunology|May 6, 2010
Hematopoietic stem cell transplantation in multiple sclerosis: a review of the clinical experience and a report of an international meetingDimitrios Karussis, Adi Vaknin-Dembinsky
Current Treatment Options in Neurology|March 12, 2013
Central nervous system vasculitisMarc Gotkine, Adi Vaknin-Dembinsky
Journal of Neuroimmunology|August 14, 2021
COVID-19 in Cladribine-treated patient with multiple sclerosisNitsan Haham, Adi Vaknin-Dembinsky
Current Treatment Options in Neurology|March 9, 2012
Neurologic manifestations of systemic immunopathological diseasesMarc Gotkine, Adi Vaknin-Dembinsky
Journal of the Neurological Sciences|May 25, 2007
Relationship of immunologic abnormalities and disease stage in multiple sclerosis: implications for therapyAdi Vaknin-Dembinsky, Howard L Weiner
Multiple Sclerosis and Related Disorders|February 17, 2019
Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disordersLivnat Brill, Iris Lavon, Adi Vaknin-Dembinsky
Current Stem Cell Research & Therapy|October 20, 2010
Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotectionIbrahim Kassis, Adi Vaknin-Dembinsky, Dimitrios Karussis
Journal of Neuroimmunology|September 25, 2018
Reduced expression of the IL7Ra signaling pathway in Neuromyelitis opticaLivnat Brill, Iris Lavon, Adi Vaknin-Dembinsky
Frontiers in Neurology|December 18, 2025
Brain atrophy in NMOSD and MOGAD: a meta-analysis of volumetric and DTI biomarkersAriel Rechtman, Omri Zveik, Adi Vaknin-Dembinsky
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 productionAdi Vaknin-Dembinsky, Konstantin Balashov, Howard L Weiner
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Expert Review of Clinical Immunology|May 6, 2010
Hematopoietic stem cell transplantation in multiple sclerosis: a review of the clinical experience and a report of an international meetingDimitrios Karussis, Adi Vaknin-Dembinsky
Current Treatment Options in Neurology|March 12, 2013
Central nervous system vasculitisMarc Gotkine, Adi Vaknin-Dembinsky
Journal of Neuroimmunology|August 14, 2021
COVID-19 in Cladribine-treated patient with multiple sclerosisNitsan Haham, Adi Vaknin-Dembinsky
Current Treatment Options in Neurology|March 9, 2012
Neurologic manifestations of systemic immunopathological diseasesMarc Gotkine, Adi Vaknin-Dembinsky
Journal of the Neurological Sciences|May 25, 2007
Relationship of immunologic abnormalities and disease stage in multiple sclerosis: implications for therapyAdi Vaknin-Dembinsky, Howard L Weiner
Multiple Sclerosis and Related Disorders|February 17, 2019
Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disordersLivnat Brill, Iris Lavon, Adi Vaknin-Dembinsky
Current Stem Cell Research & Therapy|October 20, 2010
Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotectionIbrahim Kassis, Adi Vaknin-Dembinsky, Dimitrios Karussis
Journal of Neuroimmunology|September 25, 2018
Reduced expression of the IL7Ra signaling pathway in Neuromyelitis opticaLivnat Brill, Iris Lavon, Adi Vaknin-Dembinsky
Frontiers in Neurology|December 18, 2025
Brain atrophy in NMOSD and MOGAD: a meta-analysis of volumetric and DTI biomarkersAriel Rechtman, Omri Zveik, Adi Vaknin-Dembinsky
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 productionAdi Vaknin-Dembinsky, Konstantin Balashov, Howard L Weiner
Pageof 9